Another GWAS study including 495 DLB cases showed that APOE4 was significantly associated in DLB subjects with AD-co-pathology when compared to those with no-co-pathology, potentially highlighting the relevance of APOE4 and its relationship to AD-like changes in DLB (Kaivola et al., 2021). Here, APOE is linked to Alzheimer disease.